Penumbra Inc
SWB:0P8
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Penumbra Inc (0P8) under the Base Case is EUR per share.
Compared with the current market price of 286 EUR, the stock appears .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What Penumbra Does
Penumbra makes medical devices that doctors use to treat blood clots and other vascular problems. Its products include catheter-based systems for removing clots, embolization devices used to block blood flow in abnormal vessels, and tools for navigating and treating vessels in the brain and body. The company sells mainly to hospitals, outpatient procedure centers, and the physicians who perform these interventions.
- Headquarters
- United States of America US
- Employees
- 4 700
- IPO date
- Sep 18, 2015
Penumbra has no economic moat
Hospitals and specialist physicians can choose among competing clot-removal and neurovascular devices, and Penumbra says decisions depend on safety, effectiveness and price. Its name and manufacturing scale do not appear to stop established rivals from offering alternatives or discounts.
Read the full moat analysis
Revenue & Expenses Breakdown
Penumbra Inc
Earnings Waterfall
Penumbra Inc
What is the Intrinsic Value of one 0P8 stock?
The intrinsic value for Penumbra Inc (0P8) under the Base Case is EUR.
Is 0P8 stock undervalued or overvalued?
Compared with the current market price of 286 EUR, the stock appears .
